Parsons James T. is a director of DiaMedica Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
DiaMedica Therapeutics Inc.
2 Jan 24
4
DiaMedica Therapeutics Inc.
2 Jun 23
4
DiaMedica Therapeutics Inc.
2 Jun 22
4
DiaMedica Therapeutics Inc.
3 Jan 22
4
Trillium Therapeutics Inc.
19 Nov 21
4
DiaMedica Therapeutics Inc.
16 Jul 21
4
Trillium Therapeutics Inc.
12 Jan 21
3
Trillium Therapeutics Inc.
4 Jan 21
4
DiaMedica Therapeutics Inc.
4 Jan 21
4
DiaMedica Therapeutics Inc.
2 Jun 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 24 | DMAC DiaMedica Therapeutics | Voting Common Shares, no par value per share | Grant | Acquire A | No | No | 2.8 | 21,428 | 60.00 k | 59,937 |
1 Jun 23 | DMAC DiaMedica Therapeutics | Stock Option Common Shares | Grant | Acquire A | No | No | 2.73 | 16,968 | 46.32 k | 16,968 |